Bambusa Therapeutics logo

Bambusa Therapeutics Funding & Investors

Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.

bambusatx.com

Total Amount Raised: $105,000,000

Bambusa Therapeutics Funding Rounds

  • Series A

    $90,000,000

    Series A Investors

    RA Capital Management
    Janus Henderson Investors
    Invus
    ADAR1 Capital Management
    Redmile Group

  • Seed

    $15,000,000

    Seed Investors

    BVF Partners
    Dawn Biopharma
    Salvia
    INCE Capital
Funding info provided by Diffbot.